Sentence	entity_1	entity_2	entity_3	entity_4	entity_5	entity_6	entity_7	entity_8	entity_9	entity_10	entity_11	entity_12	entity_13	entity_14	json	split
In human gliomas and other cancer cell lines, the accumulation of HIF - 1alpha protein under aerobic conditions requires the metabolism of glucose to pyruvate that prevents the aerobic degradation of HIF - 1alpha protein, activates HIF - 1 DNA binding activity, and enhances the expression of several HIF - 1 - activated genes including erythropoietin, vascular endothelial growth factor, glucose transporter 3, and aldolase A.	human,3,8,Organism	gliomas,9,16,Cancer	cancer cell lines,27,44,Cell	HIF - 1alpha,66,78,Gene_or_gene_product	glucose,139,146,Chemical	pyruvate,150,158,Chemical	HIF - 1alpha,200,212,Gene_or_gene_product	HIF - 1,232,239,Gene_or_gene_product	DNA,240,243,Cellular_component	HIF - 1,301,308,Gene_or_gene_product	erythropoietin,337,351,Gene_or_gene_product	vascular endothelial growth factor,353,387,Gene_or_gene_product	glucose transporter 3,389,410,Gene_or_gene_product	aldolase A,416,426,Gene_or_gene_product	"[{""token"": ""human"", ""start_span"": 3, ""end_span"": 8, ""type"": ""Organism""}, {""token"": ""gliomas"", ""start_span"": 9, ""end_span"": 16, ""type"": ""Cancer""}, {""token"": ""cancer cell lines"", ""start_span"": 27, ""end_span"": 44, ""type"": ""Cell""}, {""token"": ""HIF - 1alpha"", ""start_span"": 66, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""glucose"", ""start_span"": 139, ""end_span"": 146, ""type"": ""Chemical""}, {""token"": ""pyruvate"", ""start_span"": 150, ""end_span"": 158, ""type"": ""Chemical""}, {""token"": ""HIF - 1alpha"", ""start_span"": 200, ""end_span"": 212, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1"", ""start_span"": 232, ""end_span"": 239, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 240, ""end_span"": 243, ""type"": ""Cellular_component""}, {""token"": ""HIF - 1"", ""start_span"": 301, ""end_span"": 308, ""type"": ""Gene_or_gene_product""}, {""token"": ""erythropoietin"", ""start_span"": 337, ""end_span"": 351, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 353, ""end_span"": 387, ""type"": ""Gene_or_gene_product""}, {""token"": ""glucose transporter 3"", ""start_span"": 389, ""end_span"": 410, ""type"": ""Gene_or_gene_product""}, {""token"": ""aldolase A"", ""start_span"": 416, ""end_span"": 426, ""type"": ""Gene_or_gene_product""}]"	train
Strong staining for bFGF was also found in cardiac muscle fibers, smooth muscle cells of mid - size blood vessels, the gut and the myometrium, in central nervous system neurons and cerebellar Purkinje cells, and on epithelial cells of the bronchi, colon, endometrium, and sweat gland ducts of the skin.	bFGF,20,24,Gene_or_gene_product	cardiac muscle fibers,43,64,Cell	smooth muscle cells,66,85,Cell	blood vessels,100,113,Multi	gut,119,122,Organism_subdivision	myometrium,131,141,Multi	central nervous system neurons,146,176,Cell	cerebellar Purkinje cells,181,206,Cell	epithelial cells,215,231,Cell	bronchi,239,246,Multi	colon,248,253,Multi	endometrium,255,266,Multi	sweat gland ducts,272,289,Multi	skin,297,301,Organ	"[{""token"": ""bFGF"", ""start_span"": 20, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""cardiac muscle fibers"", ""start_span"": 43, ""end_span"": 64, ""type"": ""Cell""}, {""token"": ""smooth muscle cells"", ""start_span"": 66, ""end_span"": 85, ""type"": ""Cell""}, {""token"": ""blood vessels"", ""start_span"": 100, ""end_span"": 113, ""type"": ""Multi""}, {""token"": ""gut"", ""start_span"": 119, ""end_span"": 122, ""type"": ""Organism_subdivision""}, {""token"": ""myometrium"", ""start_span"": 131, ""end_span"": 141, ""type"": ""Multi""}, {""token"": ""central nervous system neurons"", ""start_span"": 146, ""end_span"": 176, ""type"": ""Cell""}, {""token"": ""cerebellar Purkinje cells"", ""start_span"": 181, ""end_span"": 206, ""type"": ""Cell""}, {""token"": ""epithelial cells"", ""start_span"": 215, ""end_span"": 231, ""type"": ""Cell""}, {""token"": ""bronchi"", ""start_span"": 239, ""end_span"": 246, ""type"": ""Multi""}, {""token"": ""colon"", ""start_span"": 248, ""end_span"": 253, ""type"": ""Multi""}, {""token"": ""endometrium"", ""start_span"": 255, ""end_span"": 266, ""type"": ""Multi""}, {""token"": ""sweat gland ducts"", ""start_span"": 272, ""end_span"": 289, ""type"": ""Multi""}, {""token"": ""skin"", ""start_span"": 297, ""end_span"": 301, ""type"": ""Organ""}]"	train
Treatment with pharmacological inhibitors and small interfering RNAs reveal that induction and activation of Sp1, HIF1alpha, and Stat3 facilitate their nuclear localization and binding to their specific motifs of the VEGF promoter and induce VEGF expression via two independent pathways, DCN / EGFR / phosphoinositide - 3 kinase / AKT and DCN / EGFR / ERK1 / 2, respectively, in DCN synthesizing MCE cells.	Sp1,109,112,Gene_or_gene_product	HIF1alpha,114,123,Gene_or_gene_product	Stat3,129,134,Gene_or_gene_product	VEGF,217,221,Gene_or_gene_product	VEGF,242,246,Gene_or_gene_product	DCN,288,291,Gene_or_gene_product	EGFR,294,298,Gene_or_gene_product	phosphoinositide - 3 kinase,301,328,Gene_or_gene_product	AKT,331,334,Gene_or_gene_product	DCN,339,342,Gene_or_gene_product	EGFR,345,349,Gene_or_gene_product	ERK1 / 2,352,360,Gene_or_gene_product	DCN,379,382,Gene_or_gene_product	MCE cells,396,405,Cell	"[{""token"": ""Sp1"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF1alpha"", ""start_span"": 114, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}, {""token"": ""Stat3"", ""start_span"": 129, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 217, ""end_span"": 221, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 242, ""end_span"": 246, ""type"": ""Gene_or_gene_product""}, {""token"": ""DCN"", ""start_span"": 288, ""end_span"": 291, ""type"": ""Gene_or_gene_product""}, {""token"": ""EGFR"", ""start_span"": 294, ""end_span"": 298, ""type"": ""Gene_or_gene_product""}, {""token"": ""phosphoinositide - 3 kinase"", ""start_span"": 301, ""end_span"": 328, ""type"": ""Gene_or_gene_product""}, {""token"": ""AKT"", ""start_span"": 331, ""end_span"": 334, ""type"": ""Gene_or_gene_product""}, {""token"": ""DCN"", ""start_span"": 339, ""end_span"": 342, ""type"": ""Gene_or_gene_product""}, {""token"": ""EGFR"", ""start_span"": 345, ""end_span"": 349, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK1 / 2"", ""start_span"": 352, ""end_span"": 360, ""type"": ""Gene_or_gene_product""}, {""token"": ""DCN"", ""start_span"": 379, ""end_span"": 382, ""type"": ""Gene_or_gene_product""}, {""token"": ""MCE cells"", ""start_span"": 396, ""end_span"": 405, ""type"": ""Cell""}]"	valid
Ba / F3 cells transformed to growth factor independence by various oncogenic PTKs ( TEL / JAK2, TEL / TRKC, TEL / ABL, BCR / ABL, FLT3 - ITD, and H4 / PDGFbetaR) show abundant expression of PIM - 1 and PIM - 2.	Ba / F3 cells,0,13,Cell	TEL,84,87,Gene_or_gene_product	JAK2,90,94,Gene_or_gene_product	TEL,96,99,Gene_or_gene_product	TRKC,102,106,Gene_or_gene_product	TEL,108,111,Gene_or_gene_product	ABL,114,117,Gene_or_gene_product	BCR,119,122,Gene_or_gene_product	ABL,125,128,Gene_or_gene_product	FLT3 - ITD,130,140,Gene_or_gene_product	H4,146,148,Gene_or_gene_product	PDGFbetaR,151,160,Gene_or_gene_product	PIM - 1,190,197,Gene_or_gene_product	PIM - 2,202,209,Gene_or_gene_product	"[{""token"": ""Ba / F3 cells"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Cell""}, {""token"": ""TEL"", ""start_span"": 84, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""JAK2"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""TEL"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""TRKC"", ""start_span"": 102, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}, {""token"": ""TEL"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Gene_or_gene_product""}, {""token"": ""ABL"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}, {""token"": ""BCR"", ""start_span"": 119, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""ABL"", ""start_span"": 125, ""end_span"": 128, ""type"": ""Gene_or_gene_product""}, {""token"": ""FLT3 - ITD"", ""start_span"": 130, ""end_span"": 140, ""type"": ""Gene_or_gene_product""}, {""token"": ""H4"", ""start_span"": 146, ""end_span"": 148, ""type"": ""Gene_or_gene_product""}, {""token"": ""PDGFbetaR"", ""start_span"": 151, ""end_span"": 160, ""type"": ""Gene_or_gene_product""}, {""token"": ""PIM - 1"", ""start_span"": 190, ""end_span"": 197, ""type"": ""Gene_or_gene_product""}, {""token"": ""PIM - 2"", ""start_span"": 202, ""end_span"": 209, ""type"": ""Gene_or_gene_product""}]"	test
Several possible explanations for the relationship of these changes to the enhancement of DMBA carcinogenesis include: radiation blocking normal capillary proliferative and / or dilatory responses to inflammation secondary to neoplastic changes; radiation - induced focal increases in the pericapillary connective tissue histohematic barrier, stimulating angiogenesis but reducing nutrient diffusion; radiation exposures sensitizing vascular endothelium to subsequent angiogenic stimulation from premalignant tissues; DMBA vascular and epithelial effects partially or completely blocking radiation effects on epithelial and / or endothelial cells; and radiation damage to vessel walls partially or fully inhibiting normal physiologic mechanisms of repairing DMBA damage to the vessels.	DMBA,90,94,Chemical	capillary,145,154,Tissue	pericapillary connective tissue,289,320,Tissue	histohematic barrier,321,341,Multi	vascular endothelium,433,453,Tissue	premalignant tissues,496,516,Tissue	DMBA,518,522,Chemical	vascular,523,531,Multi	epithelial,536,546,Tissue	epithelial,609,619,Cell	endothelial cells,629,646,Cell	vessel walls,672,684,Multi	DMBA,758,762,Chemical	vessels,777,784,Multi	"[{""token"": ""DMBA"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Chemical""}, {""token"": ""capillary"", ""start_span"": 145, ""end_span"": 154, ""type"": ""Tissue""}, {""token"": ""pericapillary connective tissue"", ""start_span"": 289, ""end_span"": 320, ""type"": ""Tissue""}, {""token"": ""histohematic barrier"", ""start_span"": 321, ""end_span"": 341, ""type"": ""Multi""}, {""token"": ""vascular endothelium"", ""start_span"": 433, ""end_span"": 453, ""type"": ""Tissue""}, {""token"": ""premalignant tissues"", ""start_span"": 496, ""end_span"": 516, ""type"": ""Tissue""}, {""token"": ""DMBA"", ""start_span"": 518, ""end_span"": 522, ""type"": ""Chemical""}, {""token"": ""vascular"", ""start_span"": 523, ""end_span"": 531, ""type"": ""Multi""}, {""token"": ""epithelial"", ""start_span"": 536, ""end_span"": 546, ""type"": ""Tissue""}, {""token"": ""epithelial"", ""start_span"": 609, ""end_span"": 619, ""type"": ""Cell""}, {""token"": ""endothelial cells"", ""start_span"": 629, ""end_span"": 646, ""type"": ""Cell""}, {""token"": ""vessel walls"", ""start_span"": 672, ""end_span"": 684, ""type"": ""Multi""}, {""token"": ""DMBA"", ""start_span"": 758, ""end_span"": 762, ""type"": ""Chemical""}, {""token"": ""vessels"", ""start_span"": 777, ""end_span"": 784, ""type"": ""Multi""}]"	test
